A recent study highlighted the crucial roles of CD4+ and CD8+ T cells in the therapeutic efficacy of BCG for bladder cancer treatment.[13] Therefore, further investigation is warranted to explore the effects of BCG in other cancer models. Here, CD4 is linked to cancer.